Company intelligence / Profile preview

The Urology Company

Slough, Berkshire, United Kingdom

Ownership: Private
Development stage: Other

Overview

The Urology Company is a UK-based specialty pharmaceutical firm dedicated to the urology and men's health therapeutic areas. The company specialized in the commercialization of treatments for erectile dysfunction, most notably Viridal Duo (alprostadil). In July 2015, the company was acquired by Ferring Pharmaceuticals, a move that integrated its portfolio into Ferring's global urology business. Today, it operates as a subsidiary within the Ferring Group, continuing to support urological health solutions in the United Kingdom.

Therapeutic areas: Men's Health
Modalities: Small molecule
Industry: Biotech

Partnerships

Apricus Biosciences

Beyond the preview

Go deeper on The Urology Company.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on The Urology Company.

Explore the full profile